Previous Page  15 / 17 Next Page
Information
Show Menu
Previous Page 15 / 17 Next Page
Page Background

Page 36

Notes:

conferenceseries

.com

Volume 5, Issue 7 (Suppl)

J Infect Dis Ther, an open access journal

ISSN: 2332-0877

Infection Prevention 2017

December 14-15, 2017

December 14-15, 2017 | Rome, Italy

13

th

World Congress on

INFECTION PREVENTION AND CONTROL

The importance of infection control risk assessment in healthcare settings

Zarina Bee Nazeer

ICC Armed Forces Hospital , Saudi Arabia

Introduction:

Patient Safety and Quality Patient Care is the ultimate goal of patient care in any healthcare facility. Infection

Prevention and Control is the epicenter of Patient Care Delivery, therefore the Infection Control Programme in Healthcare

Settings must include the IC Risk Assessment policy which must be proactively done to prevent infections and outbreaks, by

assessing the potential risks which may disrupt the IC efforts.

Infection Control Risk Assessment (ICRA):

Infection Prevention and Control (PCI) Risk Assessment describes the Infection

risks which is unique to the institution. This Infection Control Risk Assessment (ICRA) will help the institution to assess the

Complexity of the Risk identified and the possible actions to reduce the effects of the risk. The risk scoring will help determine

the severity of the risk and the prioritization of each risk identified. Risk assessment is an ongoing process because infection

risk changes overtime and at times rapidly. An infection control risk assessment must consider different elements before

establishing IPC policies and procedures, goals and objectives. A written, hospital wide comprehensive risk assessment plan

is essential in any healthcare organization because it is a first step in a systematic process to create and implement PCI Plan.

Infection Control Risk Assessment Plan:

The Healthcare Accreditation bodies (viz. JCIA – Standard PCI.7) has included

the ICRA as a requirement for written risk assessments documenting how the healthcare facility is prioritizing patient and

healthcare worker safety. The PCI Risk Assessment will be done by the Multidisciplinary Team members which may include

representation from Infection Control , Environmental Health and Safety( EH&S) , Facilities & Engineering and Continuous

Quality Improvement and Patient Safety (CQI&PS). The infection control committee members will review and approve the

facility wide PCI Risk Assessment and the PCI programme Plan for the set year. The documents will include the following:

assessment of risk, assessment of services provided, and assessment of the population served, prioritized strategies to decrease

the risk, PCI Plan for the set year. The plan is formally reviewed at least annually and whenever significant changes occur in

the elements that affects risk.

Biography

Zarina Bee Nazeer has completed her Diploma in Nursing (General, Psychiatric, Community) and Midwifery from Natal College of Nursing, R K Khan Campus

Durban South Africa. She has passed the SAMTRAC course by NOSA, safety management and training cum laude in 2001. She has completed the Infection

Prevention and Control Course in 2011 at Netcare Nursing Academy in Durban South Africa. She has more than 28 years of experience in the healthcare

setting. She is currently the Infection Control Coordinator at AFHSR in Khamis Mushayt KSA. She has been a speaker on infection control topics locally and

internationally. She is a presentor at AFHSR IC Mandatory Training course for all staff. She has coordinated, co-directed and facilitated IC educational activities and

has been extensively involved in major infection control activities, projects and programs for the past 15 years, including commissioning of new facilities, developing

surveillance programs and evaluating IC programs. She is an active team player and has been instrumental in the Infection Control Service element for JCIA at

AFHSR. The hospital has successfully passed the Joint Commission International Accreditation (JCIA February 2017).

zdacc@rocketmail.com

Zarina Bee Nazeer, J Infect Dis Ther 2017, 5:7(Suppl)

DOI: 10.4172/2332-0877-C1-035